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ABSTRACT
Yeast membrane (1,3)-β-glucan synthase (GS; EC 2.4.1.34) activity was assayed by a fluorescent dye-binding method and a conventional radioactivity method to compare its in vitro inhibition by the echinocandin-class antifungal compound. In the fluorescence
method, GS-containing microsomal plasma membrane was first reacted with UDP-glucose substrate to form the 1,3-β-glucan product.
The product was then solubilized and bound specifically with aniline blue to form a 1,3-β-glucan-fluorochrome dye complex for
reporting the GS activity. The effect of each component in the GS assay buffer on fluorescence was examined. A calibration curve was
constructed using yeast glucan as standard. In addition, the GS activities using the same amount of 1 µg/µL microsomal concentration
in the two assays were compared. The radioactivity assay showed 38.3 µM UDP-glucose incorporation and corresponded to the
formation of equivalent 262 µM yeast glucan in the fluorescent assay. It indicated a possible underestimation of 1,3-β-glucan products
in the radioactivity assay or an overestimation of the products in the fluorescence assay. However, pneumocandin A0 exhibited an IC50
value of 1.25 µM in the fluorescent assay closely comparable with that of 1 µM in the radioactivity assay. In summary, both the fluorescence and radioactivity tests generated similar data and pneumocandin inhibited GS. Possible limitations in the radioactivity assay
were also discussed.
Key words: 1,3-β-glucan synthase, aniline blue, antifungal, yeast, echinocandin

INTRODUCTION
The 1,3-β-glucan synthase (GS; EC 2.4.1.34) located
in the plasma membrane not only catalyzes the biosynthesis
of (1,3)-β-glucan, which is an essential structural polymer
of fungal cell wall, but is also a potential antifungal target
against pathogenic yeasts(1). Drugs used in chemotherapy
are designed to distinguish plant and animal hosts from
fungal pathogens. The ideal antifungal drug is one which
has no adverse effects on the host but has a broad spectrum
of action. Current therapeutic antifungal agents include
amphotericin B, a polyene antibiotic that binds to the
sterols of cell membranes and leads to cellular leakage(2), 5fluorocytosine which interferes with DNA and RNA
synthesis(3), or azole compounds which inhibit cytochrome
p-450 enzyme in fungal endoplasmic reticulum and lead to
the inhibition of ergosterol synthesis(4). Although all of the
above drugs are being used clinically, they may introduce
toxicity to host cells and cause side effects. This fact
results in the selection of GS as an alternative drug target.
Preclinical antifungal drugs which inhibit specific fungal
targets and yet cause minimal toxicity to the host have been
intensely investigated for decades. Antifungals against GS
originate from microbial sources and are structurally classified into three groups. One is the cyclic lipopeptide
echinocandin B (ECB)-like inhibitors such as aculeacin
* Author for correspondence. Tel: +886-2-24622192 ext. 5132;
Fax: +886-2-24634203; E-mail: irisko@mail.ntou.edu.tw

A(5), cilofungin(6), pneumocandins(7), and LY 303366(8).
Another group of GS-targeting antifungals is the cyclic glycolipids such as papulacandin B(9), L-687,781(10) and BU4794F(11). ECB-class GS inhibitors or their combination
with conventional antifungal drugs have been clinically
evaluated in treating immunocompromised individuals such
as HIV patients who suffer from opportunitistic fungal
infections (12). The third class of GS inhibitor was the
recently found acidic terpenoid(13).
Usually GS activity is assayed in a radioactive
system(14), GS activity is calculated by the incorporation of
isotope-labeled UDP-[14C]-glucose substrate into 1,3-βglucan polymers, which are trapped on filter discs after separating unreacted substrate by serial washing. GS inhibition assay for the in vitro antifungal activity of tested
compounds thus measures the reduced levels of substrate
incorporation in the reaction mixture. However, the
radioactive UDP-[14C]Glc is expensive, and the washing
waste is not environmentally safe. These concerns led to
our objective of using the fluorescence-based, non-radioisotopic assay as a substitute in measuring GS activity and its
inhibition in the research laboratory.
Aniline blue, a known fluorochromal triarylmethane,
has long acted as a fluorescent probe in botanical histochemistry or structural topology studies for staining the
wound-induced sugar, “callose”, on the plant’s new cell
wall (15-17) . It is also applied in staining the septum
(budding scar) of the live fission yeast Schizosaccha-
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romyces pombe for cell cycle kinetic studies(18). Recent
report showed its use in labeling cell wall 1,3-β-glucans for
characterizing Pneumocystis carinni which is a major cause
of opportunistic infection in AIDS patients(19). The active
fluorophore 4,4’-[carbonyl-bis(benzene-4,1-diyl)-bis(imino)]-bis-benzenesulfonic acid in the aniline blue dye
complex mixture is identified by mass spectroscopy, designated sirofluor. It is the major component in the dye which
can form a specific complex with 1,3-β-glucans(20). Much
attention is given to the dye in the structural-functional
activity relationship study of 1,3-β-glucans, known as biological response modifiers(21). Besides being used in the
above mentioned antifungal drug research, aniline blue has
also been used in the development of 96-well microtiter
assay for GS activity in the search for specific
inhibitors(22). The fluorescence emitted from aniline blue1,3-β-glucan complex in the absence or the presence of
increasing amount of GS-targeted inhibitors in the defined
GS assay is measured by fluorescence spectroscopy. It
shows that the microtiter assay is sensitive and is able to
reduce the cost of each GS assay in higher than 100-folds
compared to the conventional radioactivity assay.
Therefore, we adopted the fluorescence method for GS
activity assay. In this study, however, we adjusted the
method slightly by maintaining the same condition of
reaction space and time within the microfuge tube size for
GS reaction as in the conventional radioactivity method in
order to compare the two methods. Furthermore, glucan
calibration curves constructed from the fluorescence of the
yeast glucan standard bound to the aniline blue dye were
used to extrapolate the concentration of glucan formed by
GS in the fluorescence method. We also compared the
quantities of glucan formation from the fluorescence and
the conventional radioactivity method that directly reported
the molar incorporation of 14C-labeled substrate UDP-Glc
of the recovered product. Loss of water soluble glucan
signals from the radioactivity method was found and
evaluated. The IC50 values obtained by the two methods for
the antifungal in vitro activity of pneumocandin A0, an
ECB-class lipocyclopeptide which inhibits the microsomal
GS activity of C. albicans, were also compared.

MATERIALS AND METHODS
I. Materials
Bakers yeast Saccharomyces cerevisiae (ATCC2366)
and a pathogenic yeast Candida albicans (ATCC10231)
that widely used to assay for antifungal antibiotics, were
purchased from the Bioresource Collection and Research
Center (BCRC) of the Food Industry Research &
Development Institute (Hsinchu, Taiwan). Radioactive
[14C] uridine diphosphate glucose (UDP-[14C]Glc; 287.4
mCi/mmol) and liquid scintillation supplies were obtained
from NEN Life Science (Boston, MA, USA). Brij 35
(polyoxyethylene ether, 23 lauryl ether) was purchased

from Pierce (Rockford, Il USA). Guanosine 5’-O-(3-thiotriphosphate) (GTP-γ -S) was obtained from Boehringer
Mannheim (Indianapolis, IN, USA). Pneumocandin A0 was
a gift from Merck Sharp & Dohme Corp. (Rahway, NJ,
USA). Growth media were obtained from Difco (Detroit,
MI, USA). The Bradford protein assay kit was purchased
from Bio-Rad Laboratories (Richmond, CA, USA). Glass
beads were purchased from BioSpec (Bartlesville, OK,
USA). BSA (fatty acid-free), β -lactoglobulin ( β -LG),
aniline blue (Sigma M5528, CI 42780), yeast glucan
(Sigma G5011) and all the other chemicals were purchased
from Sigma Chemical Co (St. Louis, MO, USA).
II. Growth Conditions
S. cerevisiae and C. albicans were maintained on
YEPD (1% yeast extract, 2% peptone, 2% dextrose)
medium plates containing 2% (w/v) agar. Cells were first
grown at 30˚C in YEPD medium for 12 hr at 200 rpm, and
then diluted 100 times into fresh YEPD medium to grow 4
hr to mid-log phase. They were harvested by centrifugation
at 3,000 ×g for 10 min at 4˚C and then suspended and
washed with cold TE buffer (70 mM Tris-HCl, 3 mM
EDTA, pH 7.0). The suspended cells were centrifuged at
3,000 ×g for 10 min at 4˚C again to recover the cell pellets
and weighed.
III. Microsomal Membrane Preparation
Microsomal membranes were prepared by differential
centrifugation. All steps were performed on ice and centrifugation was set at 4˚C. Wet cell paste was first
suspended in cold homogenizing buffer containing 25 mM
sucrose, 3 mM EDTA, 25 µM GTP, 25 mM β -mercaptoethanol, 3 mM EGTA, 2 mM dithiothreitol (DTT), 1 mM
phenylmethylsulfonyl fluoride (PMSF) and 70 mM TrisHCl (pH 7.5 ) at 5 g/mL ratio. Then cells were mixed with
prechilled 0.5 mm glass beads at 16 g/25 mL ratio and
homogenized by a Bead Beater (Biospec products
Bartlesville, OK, USA). The beater was installed inside a
cold jacket filled with ice water. Cell solution was operated
with five 20s bursts at 5 min cooling intervals.
The homogenate was centrifuged for 10 min at
1,500 ×g to remove cell debris. The supernatant was centrifuged again at 23,000 ×g for 10 min to remove mitochondrial membranes into pellet. The supernatant was
subjected to ultracentrifugation for 1 hr at 100,000 ×g to
recover microsomal membranes in the final pellet. The
membrane pellet was well suspended in cold storage buffer
(1 mM EDTA, 1 mM DTT, 33%(v/v) glycerol and 50 mM
Tris-HCl, pH 7.5) by passage through gauge 18, 23, and 26
needles successively. The resulting membrane vesicle
concentrations were adjusted to 10~20 mg/mL, and then
stored in aliquots at -80˚C. Membrane vesicles were
thawed on ice before use. Protein concentration was determined by coomassie brilliant blue dye-binding method(23)
using BSA as standard.
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IV. GS Activity Assay by Fluorescence Method
The fluorescence assay for GS activity consisted of
two stages. The first stage was GS reaction in which for
S. cerevisiae, microsomal membranes (0 - 4.5 µg/µL) were
suspended in 0.1 mM GTP, 1 mM EDTA, 1.4% (v/v)
glycerol, 0.8 mg/mL BSA, (for component effect, BSA or
β-LG at 0.08-8 mg/mL were used), 75 mM Tris-HCl (pH
8.0) and 1 mM UDP-Glc in a total volume of 100 µL to
react at 30˚C for 30 min. For C. albicans, assays were
conducted in a mixture of 100 µL containing final concentrations of 20 µM GTP- γ -S, 1 mM EDTA, 8% (v/v)
glycerol, 0.5% (v/v) Brij-35, 80 mM Tris-HCl (pH 7.8), 01.5 µg/µL microsomes and 2 mM UDP-Glc. The GS
reaction was terminated by an addition of 200 µL of 1.5 N
NaOH. The second stage was the aniline blue dye-binding
stage in which the above 300 µL sample was added with
30 µL of 6 N NaOH and then immediately incubated at
80˚C for 30 min to solubilize the newly formed glucan.
Then 630 µL of dye solution (ratio for 0.1% aniline blue
in water, 1 N HCl, and 1 M glycine in NaOH buffer, pH
9.5, was 40/21/59, with a final dye mix pH of 3.4) was
added to react at 50˚C for 30 min to form glucan-dye fluorochrome complex. The unbound fluorescent dye was
quenched at room temperature for 30 min while fluorescence of the bound form was measured with a fluorescence spectrophotometer (HITACHI, F-2000, Japan) at
excitation wavelength of 400 nm and emission wavelength
of 460 nm.
To construct glucan calibration curves, yeast glucan
standard at various concentrations was dissolved in 300 µL
of 1 N NaOH, followed by the second stage procedure.
Each solution was prepared at its defined concentration as
in the GS assay buffer in a total volume of 300-µL 1N
NaOH, followed by the second stage procedure to measure
its fluorescence. Effect of each component in the above
mentioned GS assay buffer on fluorescence signal was also
tested. All samples were performed in duplicates.
V. GS Activity Assay by Radioactivity Method
For S. cerevisiae, regular assays were conducted in a
mixture of 100 µL containing final concentrations of 0.1
mM GTP- γ -S, 1 mM EDTA, 1.4% (v/v) glycerol, 0.8
mg/mL BSA, 75 mM Tris-HCl (pH 8.0), 0 - 1.5 µg/µL
microsomes and 1 mM UDP-[14C]Glc (0.12 mCi /mmol).
For C. albicans, assays were conducted in a mixture of 100
µL containing final concentrations of 20 µM GTP-γ-S, 1
mM EDTA, 8% (v/v) glycerol, 0.5% (v/v) Brij-35, 80 mM
Tris-HCl (pH 7.75), 1 µg/µL microsomes and 2 mM UDP[14C]Glc (012 mCi/mmol). Reaction mixture was
incubated at 30˚C for 30 min and terminated by spotting the
whole mixture onto a Whatman GF/A 2.4 cm filter disc on
a heating block set at 120˚C to dry for 10 min. Then, the
filter discs were washed successively with 66% (v/v)
ethanol containing 85 µM EDTA, 66% ethanol, and 70%
ethanol(24) in a filtration manifold apparatus (Millipore,

Bedford, Mass, USA). Each filter disc which contained the
trapped ethanol-insoluble [14C]-glucan product polymer
was added with 5 mL of scintillation cocktail and measured
by a scintillation counter (Beckman LS-6500, Beckman
Coulter, Inc. Fullerton, CA). All samples were conducted
in duplicates.
To measure the loss of glucan products during the
washing step in the radioactivity assay, the experiment was
performed similarly as described above except that only
unlabelled UDP-Glc substrate was used. In addition,
during the washing step, the filtrate fractions from the
manifold apparatus were collected separately in test tubes
inside the apparatus chamber. The filtrate was subjected to
centrifugation at 13,000 ×g for 10 min at 4˚C to recover the
glucan pellet. The pellet was dissolved and diluted in 300
µL of 1 N NaOH. Then, the glucans were resolubilized by
adding another 30 µL of 6 N NaOH and incubated at 80˚C
for 30 min before aniline blue dye solution was added as
described in the second stage of the fluorescence assay.

RESULTS
Before beginning of experiments, we optimized the
fluorescence measuring parameters for consistent fluorescent intensity and sensitivity with low background noise
from band path width and output voltage levels. The slit
width of 20 nm and output voltage of 700 for both excitation and emission conditions were determined and then
used throughout the study.
I. Construction of Glucan Fluorescence Calibration Curve
Commercial yeast glucan was used as standard to
mimic the GS product synthesized in the yeast GS reaction
to construct the glucan fluorescence calibration curve. The
calibration curves for both broad and narrow ranges were
established. Various concentrations of yeast glucan were
prepared based on its dehydroxyl glucose unit, monomer
molecular mass of 162 gm, as one mole for calculation.
Figure 1 exhibits a linear correlation between yeast glucan
concentrations within a 2000 µM broad range and the fluorescence emitted from the aniline blue-bound glucan
complex. The linearity was also obtained within a 100 µM
glucan concentration narrow range as drawn in the inlet
figure. In this study, the regression formula in the broad
range calibration curve was used to extrapolate the fluorescence intensity in the GS fluorescent activity assay into
their corresponding 1,3-β-glucan production when the net
fluorescence intensity in the sample was higher than 50. If
the net fluorescence intensity value of the sample was less
than 50, the narrow range calibration curve was used. In
other words, these two plots were used to convert the fluorescence signal into 1,3-β-glucan concentration formed in
the GS assay in order to compare the values of 1,3-β-glucan
incorporated by the radioactivity assay.
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Figure 1. The glucan fluorescence calibration curve.
The inlet figure is the standard curve of small concentration range.
The stock 2000 µM yeast glucan was first prepared in 1N NaOH
solution. It was then dissolved at 80˚C for 30 min before preparing
various concentrations in 1N NaOH with final sample volumes of
300 µL. Aniline blue binding with glucan was then conducted from
the second stage as described in the material and methods section.
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Figure 2. The effect of protein components on the fluorescence of
aniline blue.
Various concentrations of BSA or β-lactoglobulin were first prepared
in 100 µL of 75 mM Tris-HCl (pH 8.0) buffer and added with 200 µL
of 1.5 N NaOH. Aniline blue binding was then conducted from the
second stage as described in the material and methods section.
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It is known that any substance containing aromatic
groups or conjugated double bonds is a potential fluorophore which exhibits fluorescence when energy is excited
high enough at a desirable wavelength(25). Therefore, we
tested whether there is interfering fluorescence from each
individual component in the GS assay buffer for S. cerevisiae and C. albicans including BSA, β-LG, GTP, EDTA,
glycerol, Brij-35, Tris-HCl, and UDP-Glc. It was assumed
that they might disturb the fluorescence of aniline blue
when their solution was excited at 400 nm and fluorescence
emission was measured at 460 nm. Results showed that
only components of protein nature (BSA and β-LG) for S.
cerevisiae possessed fluorescence (Figure 2). BSA of 0.08
to 8 mg/mL concentrations exhibited fluorescence of 70 to
764 units, and an average of half the values were also found
to be associated with β-LG, suggesting that their concentrations in the GS assay buffer were necessarily to be
minimized. Therefore, in order to avoid the background
fluorescence of these protein components, but maintain
decent GS activities and reflect only the fluorescence from
aniline blue-bound glucan products in the GS fluorescence
activity assay, both BSA and β-LG in the GS assays were
modified to 0.8 mg/mL. This concentration was amounted
to 1/10 of their original uses for S. cerevisiae in both
radioactive and fluorescent assays.
III. GS Activity Assay for S. Cerevisiae by Fluorescence
Method
Similar to the above concerns, the existence of microsomal proteins, also possessing potential fluorescence from
the aromatic amino acids, caused interference in the fluores-
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II. The Effect of Assay Buffer Components on Fluorescence
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Figure 3. GS activity assay for yeast microsomes by the fluorescence
method.
Yeast microsomes and the heat-inactivated forms were assayed in
parallel for the dye-induced fluorescence of glucan products after GS
reaction. The inlet figure is plotted from the net fluorescence of GS
synthesized glucan, which was obtained by subtracting the fluorescence of glucan product of yeast microsomes from that of heat-inactivated forms after GS reaction. Heat-inactivated yeast microsome
samples were prepared by heating a solution of 20 mg/mL microsomes at 100˚C for 10 min before preparing the first stage 100 µL of
GS reaction mixtures.

cence GS assay as expected. Therefore, to make the fluorescence approach qualify for GS assay, this protein effect
was corrected by deducting the fluorescence of heat-inactivated microsome samples from the same amount of active
microsome counterparts after their GS reactions were conducted in parallel. In this experiment, increasing levels of
yeast microsomes of the paired samples were performed
(Figure 3). A linear correlation was again obtained between
the net fluorescence from the glucan synthesized and the
concentration of microsomes incubated in the GS reaction
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IV. GS Activity Assay for S. cerevisiae by Radioactivity
Method
In the radioactivity method, GS activity was expressed
as the unit time production of the moles of UDP-14C-Glc
incorporation into the alcohol-insoluble glucan product,
which was trapped on filter discs after filtration and
washing process. The GS substrate in this radioactive
assay consisted of a mixture of isotope labeled UDP-14CGlc and unlabeled UDP- 12 C-Glc (hot/cold mix). The
specific radioactivity for the final concentration of 1 mM
hot/cold UDP- 14 C-Glc substrate used in 100 µL assay
volume for S. cerevisiae was 0.12 mCi/mmole (2.64 × 108
cpm/mmole, counting efficiency = 1). Therefore, the total
radiation of 26,400 cpm amounted to the given total 100
nmole of UDP-Glc substrate molecules. According to the
radiation counting of the trapped product, the moles of
UDP-Glc incorporation were calculated from the ratio of
the radiation of the product to the given 26,400 cpm, which
was then multiplied by 100 nmole of UDP-Glc. The UDPGlc conversion in molarities in the reaction solution was
then derived as noted in Figure 4. Figure 4 shows that
there was linear correlation of microsome concentration
either with product radiation or with incorporated UDP-Glc
concentration, indicating that GS activity measured by the
radioactive assay was apparently also in a dose-dependent
manner (Figure 4).
100
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UDP-Glc conversion (µM)
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60
1000
40
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20

UDP-Glc conversion (µM)

Radiation (cpm)
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0

S. cerevisiae microsome (µg/µL)

Figure 4. GS activity assay for yeast microsomes by the radioactivity
method.
The left ordinate shows the radiation counting (cpm) from the glucan
product. The right ordinate shows the corresponding concentration of
converted substrate UDP-glucose (µM) into the glucan polymers.
Concentration of UDP-Glc conversion (µM) = Net radiation (cpm)/
total 26,400 (cpm) × 100 nmole/0.1 mL. Net radiation was obtained
from the difference between yeast microsomes and heat-inactivated
microsomes after GS reaction.

Owing to the reasoning that 1,3-β-glucan product is
the reporter for GS activity, the concentrations of glucan
formation in both methods were compared based on
assaying the same enzyme source of microsomes at 1
µg/µL. In the fluorescence method, Figure 1 and Figure 3
were integrated in which the corresponding net fluorescence value of GS product formed by 1 µg/µL yeast
microsome (~118 units in Figure 3 inlet) was used to
calculate the concentration of yeast glucan formation from
the regression formula in Figure 1. 38.3 µM UDP-Glc
incorporation (Figure 4) was detected with the radioactivity
method, and it corresponded to the detection of equivalent
262 µM yeast glucan formation with the fluorescence
method. Thus, it seemed that there was a seven-fold difference of the reported signals between the two methods.
V. Evidence of Undetected 1,3- β-glucan Product in the
Filtrate of the Radioactive Assay
The seven-fold difference possibly implied an underestimation of 1,3-β-glucan product in the radioactive assay.
We thus examined this possibility by collecting the filtrate
fractions from a modified radioactive assay for C. albicans
microsomes, followed by fluorescent assay to detect
whether any 1,3-β-glucans products might be washed into
the filtrate and escaped from the filter discs for counting.
We found the filtrate collection from the unlabeled GS
assay of C. albicans indeed contained 1,3-β-glucan
300
Filter-trapped glucan
250

Fluorescence (unit)

(Figure 3 inlet graph). It demonstrated that GS activity
measured by the fluorescent assay was apparently in a dosedependent manner. The net fluorescence value of the GS
assay was used to calculate the amount of 1,3-β-glucan produced from the glucan calibration curves (Figure 1).
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Figure 5. Glucan was found in the filtrate fraction during washing of
the GS assay products for C. albicans.
Various concentrations of GS-containing C. albicans microsomes
were used in the first stage GS assays in the two sample sets. After
GS reaction, one set of the reaction mixtures was put directly through
the second stage aniline blue binding experiment to record the fluorescence from total glucan products (the total glucan line). Another
set of the reaction mixtures was spotted onto the filter discs and
washed successively with 66% (v/v) ethanol containing 85 µM
EDTA, 66% ethanol, and 70% ethanol as described in the radioactive
assay, in order to collect the filtrate fractions. The filtrate fractions
were then subjected to assaying glucan content by the fluorescent
assay (the filtrate glucan line).
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products (Figure 5). And there was actually up to 20% loss
of glucan during the serial washing steps.

Fluorescent assay
Radioactive assay

VI. Comparison of Antifungal Activity of Pneumocandin Ao
in the Fluorescent and Radioactive Assays
We used pneumocandin A0(26) as a positive control
compound to compare its antifungal activities against
pathogenic C. albicans GS in the two methods. Its fluorospectral feature was similar to that of pneumocandin
B0, which exhibited an excitation maximum at 275 nm
and an emission maximum at 303 nm (27) and had no
interference with the fluorescent reporter, aniline blue,
which measured at Ex 400 nm/Em 460 nm. Besides,
there was no nonspecific fluorescence quenching to the
emission of aniline blue-bound glucan complex by pneumocandin A 0 when it was added into the GS assay
mixture. Figure 6 shows that pneumocandin A0 had IC50
value of 1 µM from the radioactivity method and 1.25
µM from the fluorescence method.

DISCUSSION
This study reports a modified version of the microtiterbased method(22) to detect GS activities for antifungal assay
in a common research laboratory, where the microplate fluorescence reader is not usually available. We relied on the
principle of fluorescence detection as a good approach to
resolving the safety problem of the waste caused by the
conventional radioactivity method. However, by comparing
the formation of 1,3-β-glucan product with the same
amount of yeast microsomes at 1 µg/µL, we calculated a
seven-fold difference in the two GS assay systems. This
outcome difference might be raised by either an overestimation from the fluorescence method or underestimation from
the radioactivity method. We propose several possible
reasons as follows. The first is the non-homogeneity of the
commercial yeast glucan products; some of which might
have been contaminated with residual yeast cell wall components such as mannan and chitin, resulting in overcounting of the real number of glucan molecules in the sampling
weight during the construction of glucan fluorescence
standard curve. Therefore, the fluorescence value was contributed by the 1,3-β-glucan portion from a given amount of
heterogeneous yeast glucan products. This factor was able
to cause overestimation of the glucan product when we did
the fluorescence conversion with the standard curve in
Figure 1. Yeast mannan in particular exhibited 1/52 of the
aniline blue-induced fluorescence upon binding as
compared to yeast glucan examined previously(20). This
factor may also cause minor miscalculation of glucan
product concentration from the corresponding fluorescence
value in Figure 1.
Secondly, the aniline blue has bound with the newly
synthesized glucan products much stronger than with the
standard yeast glucan, resulting in higher fluorescence
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Figure 6. A comparison of the inhibition of GS activity of C.
albicans microsomes by pneumocandin A0 between the radiation and
fluorescence assays.
Pneumocandin A0 was prepared in DMSO of various concentrations
in 10 µL. It was incubated with GS reaction mixture for 10 min on
ice before UDP-Glc was added for both assays. The DMSO at 10 µL
in the GS assay mixture exhibited no influence on the fluorescence of
aniline blue.

signals that were detected within the new GS products.
Because the association of the aniline blue dye with 1,3-βglucan is dependent on its stereo-chemical conformation in
solution state (28) , the fresh product may form a better
helical structure for the dye to access easier and thus have
higher binding stoichiometry than with the yeast glucan
standard. Moreover, it was reported that the fluorescence
induced by the dye mixture might not indicate the presence
of 1,3-β-glucan due to the impurities in the aniline blue
chemical, which exhibited fluorescence upon binding with
endogenous sugars other than 1,3-β-glucan in the glucan
standard. In addition, the fluorescence might cause overestimation as well(29).
In addition to the factors discussed above, the main
variable to product quantification by the fluorescence
method was the selection of the glucan standard(22). The
1,3-β-glucan species of single helical conformation preferentially reacts with aniline blue in solution was reported(28).
If the binding behavior of a new 1,3-β-glucan standard with
the aniline blue dye changes will change the slope of the
new glucan calibration curve and change the ultimate
glucan quantification accordingly. Since enzyme specific
activity (mol min-1mg-1) is proportional to the quantity of
product formation, the application of the fluorescence assay
in enzyme kinetic study would probably not be popular
until the discovery of a homogenous, acceptable and wellrecognized source as the 1,3-β-glucan standard just as BSA
has been used as a standard for protein quantification by
the principle of protein-dye binding in the Bradford method
for decades(23). We should not, however, rule out the possibility of using the fluorescence method as a relative quantification for 1,3-β -glucans and enzyme kinetics if the
standard is a well defined 1,3-β-glucan species.
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The fluorescence assay system has affected the
detection sensitivity of the susceptibility of membrane GS
to pneumocandin A0. The 25% higher IC50 value from the
fluorescence method than from the radiation method might
be a reflection of the underestimation of synthesized glucan
in the radioactive assay as described above. However, the
difference was not as much as the seven-fold of the calculation from 1,3-β-glucan products, which was proportional
to the specific activity of GS. The much less difference
should be probably due to the fact that IC50 value is 50%
inhibition of the enzyme activity as a whole instead of 50%
of specific GS enzyme activity.
The action of ECB-class drug on GS was believed to
be noncompetitive inhibition (30) . A few reports have
demonstrated that the mechanism of GS inhibitors was the
combined effects of direct and indirect actions. For
example, the indirect inhibition on GS, by phospholipase
A2 and its reaction products, was due to the perturbation
of lipophilic fatty acid side chains of the inhibitors on the
membrane environment and the alteration of the
membrane fluidity (24). The direct visualization of the
interaction of acyl side chains of ECB-class compound
with membrane environment was demonstrated by using
the drug as an inherent fluorescence probe in the fluorescence titration and steady-state emission anisotropy
study(27). A 40 kDa protein, further identified by photoaffinity labeling, was found to involve in the direct interaction of LY303366 with GS-containing membranes(31).
Therefore, the fluorescence method in this report should
be applicable in studying the interaction of the ECB-class
antifungal drug with membrane GS in the future because
the drug and aniline blue dye possess independent fluorescence spectroscopic features.
This report shows a logistic demonstration of linkage
experiments between the quantities of the fluorescence
from the GS reaction, from the standard 1,3-β-glucans, the
membrane background fluorescence subtraction and the
radiation of glucan product. It shows that the fluorescence
method is a proper substitute for the radioactivity assay in
the detection of GS inhibitors. It supports the use of the
fluorescence method as a way to avoid the potential
drawbacks of the environmental hazard caused by radiation
waste. In conclusion, the fluorescence assay is useful both
in the GS activity studies in which the amount of glucan
formed is not a critical factor, and is useful in studying the
antifungal activity of the yeast GS-targeted inhibitory
compounds such as ECB-class drugs.
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